MRK vs PFE — stock comparison
Merck & Co., Inc. (MRK) vs Pfizer Inc. (PFE): price, valuation, margins, growth and Traddx's fundamentals grade, side by side. Free, live data.
On Traddx's fundamentals score, PFE grades higher (D 46 vs B 62). Not investment advice.
| MRK | PFE | |
|---|---|---|
| Traddx grade | D (46) | B (62) |
| Price | $149.28 | $28.72 |
| Today | 0.40% | 0.00% |
| P/E | 82.00 | 18.40 |
| Net margin | 7.00% | 14.60% |
| Revenue (TTM) | $65,975.00M | $60,792.00M |
| Debt / equity | — | 1.36 |
| 52-week high | $156.92 | $29.21 |
| 52-week low | $82.01 | $23.62 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.